P3 Health Partners, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
Profit Before Tax
-305.00
-183.00
-1,559.00
-204.00
-31.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
87.00
30.00
34.00
75.00
25.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-110.00
-76.00
-126.00
-66.00
-24.00
Cash Flow from Investing Activities
14.00
-1.00
-7.00
-56.00
3.00
Cash Flow from Financing Activities
98.00
100.00
11.00
223.00
34.00
Net Cash Inflow / Outflow
3.00
22.00
-122.00
100.00
6.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of P3 Health Partners, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-305.991
5.059
-310.00
-6148.45%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
87.977
0.652
87.00
13393.40%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-110.128
20.459
-130.00
-638.29%
Cash Flow from Investing Activities
14.525
-13.239
27.00
209.71%
Cash Flow from Financing Activities
98.771
-6.924
104.00
1526.50%
Net Cash Inflow / Outflow
3.168
0.296
3.00
970.27%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -44.85% vs 39.67% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-110.13
-76.03
-44.85%






